Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900024538Phase 4Not yet recruiting
Phase 4 trial of esmolol in postoperative pain and None (3 arms), sponsored by Second Hospital of Shandong University. Primary endpoints: Blood pressure, Heart rate and 2 more. Planned start Aug 2019; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900024538.